Related Experiment Videos
Effect of diet on posttransplant hyperlipidaemia
D Divakar1, R R Bailey, M Price
1Department of Nephrology, Christchurch Hospital.
The New Zealand Medical Journal
|March 11, 1992
Summary
Dietary management significantly improved lipid profiles in renal transplant recipients with hyperlipidemia. This approach led to a reduced cholesterol risk ratio and increased HDL cholesterol, suggesting it as an initial treatment strategy.
Area of Science:
- Nephrology
- Cardiology
- Nutritional Science
Background:
- Post-transplant hyperlipidemia is a common complication in renal transplant recipients.
- It increases the risk of cardiovascular disease, impacting long-term graft and patient survival.
Purpose of the Study:
- To evaluate the efficacy of a three-month dietary intervention in managing hyperlipidemia in stable renal transplant patients.
- To assess the impact of dietary changes on plasma lipid and apolipoprotein concentrations and lipoprotein patterns.
Main Methods:
- Twenty-five renal transplant recipients with hyperlipidemia and stable graft function participated.
- A controlled diet was implemented, focusing on reduced energy intake, restricted fat (25-30%), low saturated fat (<10%), and limited cholesterol (<300 mg/d).
- Lipid profiles, apolipoproteins, and lipoprotein electrophoresis were measured before and after the three-month dietary period.
Main Results:
- Significant reduction in the cholesterol/HDL cholesterol risk ratio and a significant increase in HDL cholesterol concentration were observed.
- Six patients normalized their lipoprotein electrophoretic patterns, with substantial decreases in total cholesterol, LDL cholesterol, and apoB/apo A-1 ratio.
- Most participants showed improvements in various lipid parameters following dietary modifications.
Conclusions:
- Dietary modification is an effective initial approach for managing hyperlipidemia in renal transplant recipients.
- This intervention can lead to significant improvements in cardiovascular risk factors, including lipid profiles.
- Further research may explore long-term outcomes and combination therapies.